Evolution progressive Que touche la maladie de Parkinson Noyaux gris centrauxMaladie de Parkinson: pas assez ou trop de dopamine? Pas assezFamille de maladie Parkinson Synucléinopathies Pourquoi la maladie de Parkinson est considérée comme une synucléinopathie? Présence de corps de Lewy...
Parkinson's disease is a neurodegenerative disorder clinically characterized by motor impairments (tremor, bradykinesia, rigidity and postural instability) associated or not with non-motor complications (cognitive disorders, dysautonomia). Most of patients loose weight during evolution of their disease. ...
Maladie de ParkinsonRenforcement musculaireRevalidationForce musculairepatient-group follows a 4-week programme (4 days a week) including motor rehabilitation (balance, gait, effort reconditioning. . .), interviews with a social worker, support groups with a psychologist, relaxation, and spa bath ...
Conversly, accumulation of brain cholesterol is associated with several neurodegenerative diseases (Huntington disease, Parkinson disease, epilepsy, Niemann Pick C disease, Alzheimer's disease). Moreover, close connections exist between molecula...
Parkinson's disease is a neurodegenerative disorder characterized by a cardinal clinical triad that comprises resting tremor, akinesia and plastic hypertonia. The main lesion is a loss of midbbrain dopaminergic neurons but throughout the disease evolution, other neuronal systems will also degenerate. ...
Parkinson's diseaseTherapyDeep brain stimulationTen years after the therapeutic revolution that emerged from the discovery of L-dopa, some pioneer teams led the rebirth of a new nonablativestereotaxical surgical treatment, which came from the interest of high frequency stimulation. Three targets were ...
This evolution signified the need to develop an effective tool to measure the effectiveness of drugs or surgery in PD and has had the Movement Disorder Society to propose 20years ago a tool to assess such patients: the Unified Parkinson's Disease Rating Scale (UPDRS). This scale has a good...
Parkinson's disease is characterized by a pure asymmetric parkinsonian syndrome, responsive to dopaminergic treatment. The evolution of Parkinson's disease is...doi:10.1016/j.neurol.2018.01.292Cousyn, LouisGrabli, DavidAzuar, CaroleLevy, Richard...